A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure

Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)

Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica

Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)

Safety and Efficacy of AMG 592 in Subjects With Active Systemic Lupus Erythematosus

Safety and Efficacy of AMG 592 in Subjects With Active Rheumatoid Arthritis

Evaluation of Efficacy and Safety of Sarilumab in Patients With GCA

A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes

A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)

Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis